![Seth Salpeter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Seth Salpeter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Curesponse Ltd.
![]() Curesponse Ltd. Packaged SoftwareTechnology Services Curesponse Ltd. develops a technology to improve cancer research and drug diagnostics. Its services include personalized cancer treatment regimen. The company was founded by Guy Neev, Seth Salpeter, and Ravid Straussman on November 5, 2017 and is headquartered in Tel Aviv, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 05.11.2017 | - |
Gründer | 05.11.2017 | - | |
Immunyx Pharma Ltd.
![]() Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Vorstandsvorsitzender | - | - |
Gründer | - | - |
Karriereverlauf von Seth Salpeter
Statistik
International
Israel | 2 |
Vereinigte Staaten | 2 |
Operativ
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Sektoral
Technology Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Curesponse Ltd.
![]() Curesponse Ltd. Packaged SoftwareTechnology Services Curesponse Ltd. develops a technology to improve cancer research and drug diagnostics. Its services include personalized cancer treatment regimen. The company was founded by Guy Neev, Seth Salpeter, and Ravid Straussman on November 5, 2017 and is headquartered in Tel Aviv, Israel. | Technology Services |
Immunyx Pharma Ltd.
![]() Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Seth Salpeter
- Erfahrung